Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bourgeois, H [1 ]
Lemerre, D [1 ]
Chicoyneau, V [1 ]
Paitry, T [1 ]
Chleze, S [1 ]
Fruge, F [1 ]
Boita, F [1 ]
Meurice, JC [1 ]
Daban, A [1 ]
机构：
[1] Reg Univ Hosp Miletrie, F-86021 Poitiers, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81462-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1042
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [31] A phase II trial of gemcitabine and ifosfamide in non-small cell lung cancer
    Gatzemeier, U
    Manegold, C
    Eberhard, W
    Wilke, HJ
    Chomy, F
    Chomy, P
    Khayat, D
    Blatter, J
    Seeber, S
    Drings, P
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 836 - 838
  • [32] Phase I study using weekly Taxol (T) and gemcitabine (G) in patients with advanced non small cell lung cancer (NSCLC)
    De Pas, T
    De Braud, F
    Sessa, C
    Nole, F
    Minchella, I
    Catania, C
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 98 - 99
  • [33] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [34] Randomized phase III study of Gemcitabine/cisplatin versus mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer (NSCLC)
    Scagliotti, G
    Crino, L
    Conte, PF
    Rinaldi, M
    De Marinis, F
    Gridelli, C
    ANNALS OF ONCOLOGY, 1998, 9 : 85 - 85
  • [35] Preliminary report on a phase I study of ifosfamide and vinorelbine (Navelbine) in advanced non-small cell lung cancer
    Masters, GA
    Hoffman, PC
    Drinkard, LC
    Watson, S
    Samuels, BL
    Golomb, HM
    Vokes, EE
    SEMINARS IN ONCOLOGY, 1996, 23 (02) : 11 - 18
  • [36] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Tabata, Masahiro
    Kozuki, Toshiyuki
    Ueoka, Hiroshi
    Kiura, Katsuyuki
    Harita, Shingo
    Tada, Atsuhiko
    Shibayama, Takuo
    Takigawa, Nagio
    Yonei, Toshiro
    Gemba, Kenichi
    Segawa, Yoshihiko
    Kishino, Daizo
    Tada, Shinya
    Hiraki, Shunkichi
    Tanimoto, Mitsune
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 53 - 59
  • [37] A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study
    Masahiro Tabata
    Toshiyuki Kozuki
    Hiroshi Ueoka
    Katsuyuki Kiura
    Shingo Harita
    Atsuhiko Tada
    Takuo Shibayama
    Nagio Takigawa
    Toshiro Yonei
    Kenichi Gemba
    Yoshihiko Segawa
    Daizo Kishino
    Shinya Tada
    Shunkichi Hiraki
    Mitsune Tanimoto
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 53 - 59
  • [38] Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer
    Shepherd, FA
    Cormier, Y
    Burkes, R
    Evans, WK
    Goss, G
    Klimo, P
    Feld, R
    Taylor, M
    SEMINARS IN ONCOLOGY, 1997, 24 (03) : 827 - 830
  • [39] Triplet chemotherapy combination with gemcitabine, cisplatin and ifosfamide in patients with advanced non-small-cell lung cancer - Phase II study
    Mohedano, NM
    Rovira, PS
    Barriuso, AL
    Morales, MF
    Magan, BM
    Morago, AJ
    Quintela, IP
    Garcia, RD
    Flores, EF
    Moreno, MAM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 363 - 365
  • [40] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
12345